CS logo
small CS logo
Klinikum Gütersloh

Gutersloh, Germany
General hospital in Gütersloh, North Rhine-Westphalia
Reckenberger Str. 19, 33332 Gütersloh

About Klinikum Gütersloh


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Daiichi Sankyo, Inc.
2
German High-Grade Non-Hodgkin's Lymphoma Study Group
2
AGO Research GmbH
1
AGO Study Group
1
Abbott Medical Devices
1
Leipzig Heart Institute GmbH
1
Universität des Saarlandes
1
Total Rows: 7

Clinical Trials at Klinikum Gütersloh


During the past decade, Klinikum Gütersloh conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11000022001100110000000000000000Started TrialsCompleted Trails201520162017201820192020202120220123
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
2001-01-01
2010-08-05
Completed
1,506
Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma
2002-04-01
2006-12-05
Completed
392
OPTIMAL>60 / DR. CHOP, Improvement of Therapy of Elderly Patients With CD20+ DLBCL Using Rituximab Optimized and Liposomal Vincristine
2011-11-01
2024-05-01
Active, not recruiting
1,152
MOre REsponse on Cardiac Resynchronization Therapy With MultiPoint Pacing
2013-12-01
2021-05-30
Terminated
5,850
Edoxaban Treatment in Routine Clinical Practice for Patients With Non Valvular Atrial Fibrillation
2015-08-01
2022-04-13
Completed
13,980
Atezolizumab With Bevacizumab and Chemotherapy vs Bevacizumab and Chemotherapy in Early Relapse Ovarian Cancer
2018-09-11
2024-12-01
Active, not recruiting
550
Re-evaluation of Optimal Re-synchronisation Therapy in Patients With Chronic Heart Failure
2018-09-01
2023-02-21
Terminated
959
Edoxaban in Patients With Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
2020-06-30
2023-06-30
Active, not recruiting
1,200

Rows per page:

1–9 of 9

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Klinikum Gütersloh" #1 sponsor was "Daiichi Sankyo, Inc." with 2 trials, followed by "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 2 trials sponsored, "AGO Research GmbH" with 1 trials sponsored, "AGO Study Group" with 1 trials sponsored and "Abbott Medical Devices" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Gütersloh" #1 collaborator was "Daiichi Sankyo Deutschland GmbH" with 1 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator, "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 1 trials as a collaborator, "Heart Center Leipzig - University Hospital" with 1 trials as a collaborator and "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.
Created with Highcharts 11.1.0Top Leading SponsorsDaiichi Sankyo, Inc.: 2Daiichi Sankyo, Inc.: 2German High-GradeNon-Hodgkin'sLymphoma StudyGroup: 2German High-GradeNon-Hodgkin'sLymphoma StudyGroup: 2AGO Research GmbH: 1AGO Research GmbH: 1AGO Study Group: 1AGO Study Group: 1Abbott Medical Devices: 1Abbott Medical Devices: 1Leipzig Heart Institute GmbH: 1Leipzig Heart Institute GmbH: 1Universität des Saarlandes: 1Universität des Saarlandes: 1

Created with Highcharts 11.1.0Top CollaboratorsDaiichi SankyoDeutschland GmbH: 1Daiichi SankyoDeutschland GmbH: 1European Network ofGynaecologicalOncological Trial Groups(ENGOT): 1European Network ofGynaecologicalOncological Trial Groups(ENGOT): 1German High-GradeNon-Hodgkin'sLymphoma StudyGroup: 1German High-GradeNon-Hodgkin'sLymphoma StudyGroup: 1Heart Center Leipzig -University Hospital: 1Heart Center Leipzig -University Hospital: 1Hoffmann-La Roche: 1Hoffmann-La Roche: 1SpectrumPharmaceuticals, Inc: 1SpectrumPharmaceuticals, Inc: 1

Clinical Trials Conditions at Klinikum Gütersloh


According to Clinical.Site data, the most researched conditions in "Klinikum Gütersloh" are "Lymphoma" (2 trials), "Atrial Fibrillation" (1 trials), "CD20+ Aggressive B-Cell Lymphoma" (1 trials), "Chronic Heart Failure" (1 trials) and "Fallopian Tube Cancer" (1 trials). Many other conditions were trialed in "Klinikum Gütersloh" in a lesser frequency.

Clinical Trials Intervention Types at Klinikum Gütersloh


Most popular intervention types in "Klinikum Gütersloh" are "Drug" (7 trials), "Biological" (2 trials), "Radiation" (2 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab" (2 trials), "Edoxaban" (2 trials), "cyclophosphamide" (2 trials), "doxorubicin hydrochloride" (2 trials) and "filgrastim" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Klinikum Gütersloh


The vast majority of trials in "Klinikum Gütersloh" are 7 trials for "All" genders and 2 trials for "Female" genders.

Clinical Trials Status at Klinikum Gütersloh


Currently, there are NaN active trials in "Klinikum Gütersloh". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Klinikum Gütersloh, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Gütersloh, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 5Phase 3: 5Not Applicable: 2Not Applicable: 2

Created with Highcharts 11.1.0Trials StatusActive, not recruiting: 3Active, not recruiting: 3Completed: 3Completed: 3Terminated: 2Terminated: 2Recruiting: 1Recruiting: 1